Ageloc Lumispa Treatment Cleanser Acne

Description

NU SKIN® age LOC® Lumi Spa™ Treatment Cleanser is a specialized formulation designed for the management of acne. This product is presented in a dosage form of 100 ml (3.4 fl. oz.), providing a targeted approach to skin cleansing and treatment.

Uses and Indications

This drug is indicated for the treatment of acne. It penetrates pores to eliminate most acne blemishes.

Dosage and Administration

Healthcare professionals are advised to instruct patients to begin by dampening the skin with warm water. Following this, an ample amount of the treatment cleanser should be applied evenly over the face, taking care to avoid the eye area. For optimal results, it is recommended that the treatment cleanser be used in conjunction with the ageLOC® LumiSpa™ device, adhering to the guidelines provided in the ageLOC LumiSpa User's Manual.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only.

When utilizing this product, healthcare professionals should be aware that the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. In the event of irritation, it is advised to limit the use to one topical acne medication at a time unless otherwise directed by a physician.

In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended without delay.

Should any irritation arise during treatment, it is imperative to discontinue use and consult a healthcare provider for further guidance.

Side Effects

Patients using this product should be aware that it is intended for external use only. The concurrent use of another topical acne medication may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is advised to limit the use to one topical acne medication at a time unless otherwise directed by a healthcare professional.

In cases of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time unless otherwise directed by a healthcare professional. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult with their doctor for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Ageloc Lumispa Treatment Cleanser Acne (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Safety and efficacy in pediatric populations have not been established, and specific dosing recommendations for children are not provided. Caution is advised when administering this medication to ensure it is not accessible to young children.

Geriatric Use

There is no specific information regarding the use of ageLOC LumiSpa Treatment Cleanser Acne in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. The use of salicylic acid during pregnancy may pose significant risks, and it is advised that pregnant patients consult a healthcare provider before use. Additionally, dosage adjustments may be necessary for pregnant individuals; therefore, healthcare professionals should be consulted for appropriate guidance regarding dosage modifications.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion.

Patients should be informed that the use of this product may increase the likelihood of skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is important to instruct patients to use only one topical acne medication at a time unless otherwise directed by a healthcare professional.

In the event of accidental ingestion, patients should be instructed to seek medical assistance immediately or contact a Poison Control Center for guidance.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ageloc Lumispa Treatment Cleanser Acne, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)